FSLZX
Price
$56.02
Change
-$0.61 (-1.08%)
Updated
Aug 20 closing price
Net Assets
2.72B
FSMAX
Price
$117.72
Change
-$1.39 (-1.17%)
Updated
Aug 20 closing price
Net Assets
40.08B
Interact to see
Advertisement

FSLZX vs FSMAX

FSLZX vs FSMAX Comparison Chart in %
View a ticker or compare two or three
VS
FSLZX vs. FSMAX commentary
Aug 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSLZX is a Buy and FSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40.1B vs. FSLZX (2.72B). FSLZX pays higher dividends than FSMAX: FSLZX (0.54) vs FSMAX (0.50). FSLZX was incepted earlier than FSMAX: FSLZX (10 years) vs FSMAX (15 years). FSLZX (0.60) is less costly to investors than FSMAX (0.04). FSLZX is a more actively managed with annual turnover of: 55.00 vs. FSMAX (23.00). FSLZX (0) and FSMAX (0) have matching initial minimum investment requirements. FSMAX annual gain was more profitable for investors over the last year : 23.68 vs. FSLZX (20.40). FSMAX return over 5 years is better than : 40.14 vs. FSLZX (21.55).
FSLZXFSMAXFSLZX / FSMAX
Total Expense Ratio0.600.041,714%
Annual Report Gross Expense Ratio0.600.041,714%
Fund Existence10 years15 years-
Gain YTD21.28216.937126%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets2.72B40.1B7%
Annual Yield % from dividends0.540.50107%
Returns for 1 year20.4023.6886%
Returns for 3 years50.6472.7470%
Returns for 5 years21.5540.1454%
Returns for 10 yearsN/A134.49-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CIICX51.040.58
+1.15%
American Funds Intl Gr and Inc 529-C
FCUCX20.460.08
+0.39%
NYLI PineStone U.S. Equity Class C
ISCGX5.500.02
+0.36%
Transamerica Small Cap Growth I
HFDCX20.760.06
+0.29%
Hartford Schroders US MidCap Opps C
FHCCX43.67N/A
N/A
Fidelity Advisor Health Care C